Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

Ataturk University

Status: Unknown

Conditions: Urinary System Stones; Pain

Treatments: Drug: Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml; Drug: 5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously

Study type: Interventional

Funder types: Other

Identifiers

NCT04213924

ESPB for ESWL

Details and patient eligibility

About

Extracorporeal shock wave lithotripsy (ESWL) is widely used in the treatment of urinary tract stones and is generally applied to outpatients. To achieve fragmentation in ESWL, shock waves must be applied with sufficient power and time. Providing effective analgesia during this procedure is crucial to the success of the procedure. Erector Spinae Plan Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in urinary system surgery. This study aimed to investigate the efficacy of ESPB in patients undergoing ESWL.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologist's physiologic state I-II patients undergoing Extracorporeal Shockwave Lithotripsy

Exclusion criteria

• chronic pain
• bleeding disorders
• renal or hepatic insufficiency
• patients on chronic non-steroidal anti-inflammatory medications
• emergency cases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Group ESPB

Active Comparator group

Description:

Ultrasound-guided erector spinae plane block with 10 ml %0.5 bupivacaine and 10 ml %2 lidocaine

Treatment:

Drug: Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml

Group NSAII

Active Comparator group

Description:

lidocaine 5% gel and 800 mg ibuprofen intravenously

Treatment:

Drug: 5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously